Segall Bryant & Hamill, LLC Veracyte, Inc. Transaction History

Segall Bryant & Hamill, LLC

$6.35 Billion
Q1 2025

A detailed history of Segall Bryant & Hamill, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 468,655 shares of VCYT stock, worth $14.3 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

468,655

Previous 433,874 8.02%

Holding current value

$14.3 Million

Previous $17.2 Million 19.13%

% of portfolio

0.22%

Previous 0.24%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 02, 2025	BUY	$29.65 - $46.14 $1.03 Million - $1.6 Million	34,781 Added 8.02%	468,655 $13.9 Million
Q4 2024 Feb 11, 2025	SELL	$31.92 - $44.4 $332,766 - $462,870	-10,425 Reduced 2.35%	433,874 $17.2 Million
Q3 2024 Nov 08, 2024	BUY	$21.0 - $35.25 $1.49 Million - $2.51 Million	71,086 Added 19.05%	444,299 $15.1 Million
Q2 2024 Aug 14, 2024	BUY	$18.86 - $23.55 $929,552 - $1.16 Million	49,287 Added 15.22%	373,213 $8.09 Million
Q1 2024 May 15, 2024	BUY	$21.0 - $29.1 $1.07 Million - $1.49 Million	51,092 Added 18.73%	323,926 $7.18 Million
Q4 2023 Feb 14, 2024	BUY	$19.72 - $28.68 $1.05 Million - $1.53 Million	53,408 Added 24.34%	272,834 $7.51 Million
Q3 2023 Nov 09, 2023	SELL	$22.33 - $29.92 $836,370 - $1.12 Million	-37,455 Reduced 14.58%	219,426 $4.9 Million
Q2 2023 Aug 11, 2023	BUY	$20.96 - $26.99 $42,632 - $54,897	2,034 Added 0.8%	256,881 $6.54 Million
Q1 2023 May 15, 2023	SELL	$20.58 - $27.89 $170,916 - $231,626	-8,305 Reduced 3.16%	254,847 $5.68 Million
Q4 2022 Feb 14, 2023	BUY	$15.31 - $29.94 $4.03 Million - $7.88 Million	263,152 New	263,152 $6.24 Million
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $4.88 Million - $8.2 Million	294,085 New	294,085 $4.88 Million
Q2 2022 Aug 15, 2022	BUY	$15.45 - $29.52 $268,922 - $513,825	17,406 Added 7.04%	264,761 $5.27 Million
Q1 2022 May 13, 2022	BUY	$21.94 - $42.51 $1.51 Million - $2.93 Million	68,985 Added 38.68%	247,355 $6.82 Million
Q4 2021 Feb 14, 2022	BUY	$36.09 - $53.79 $1.68 Million - $2.5 Million	46,549 Added 35.31%	178,370 $7.35 Million
Q3 2021 Nov 03, 2021	BUY	$35.62 - $52.97 $533,730 - $793,702	14,984 Added 12.82%	131,821 $6.12 Million
Q2 2021 Aug 12, 2021	BUY	$32.94 - $56.62 $1.55 Million - $2.66 Million	46,909 Added 67.08%	116,837 $4.67 Million
Q1 2021 May 13, 2021	BUY	$44.47 - $81.38 $3.11 Million - $5.69 Million	69,928 New	69,928 $3.76 Million

Others Institutions Holding VCYT

# of Institutions

334

Shares Held

76.4M

Call Options Held

212K

Put Options Held

18.5K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.18B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.

Account

Segall Bryant & Hamill, LLC Veracyte, Inc. Transaction History